We showed here that K-80003 is a potent inhibitor of tRXRα-mediated colorectal carcinogenesis by inhibiting tRXRα-mediated NF-κB-IL-6-STAT3 pathway (Fig. 7). Here, NFKB1 is linked to medical procedure.